David Curiel
Gründer bei Vectorlogics, Inc.
Aktive Positionen von David Curiel
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Vectorlogics, Inc.
 Vectorlogics, Inc. BiotechnologyHealth Technology Vectorlogics, Inc. develops and commercialized vaccines for virus based cancer therapies and viral liver diseases. The company was founded by David T. Curiel in 1998 and is headquartered in Birmingham, AL. | Direktor/Vorstandsmitglied | 14.12.2009 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 14.12.2009 | - | |
| Gründer | 14.12.2009 | - | |
Provecs Medical GmbH
 Provecs Medical GmbH BiotechnologyHealth Technology Provecs Medical GmbH develops therapeutic vaccines. It focuses in providing treatment options for patients with advanced cancer and infectious diseases. The company was founded by Frank Schnieders and Hansjoerg Forster in 2007 and is headquartered in Hamburg, Germany. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von David Curiel
Ehemalige bekannte Positionen von David Curiel
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01.01.1989 | 01.01.1989 |
Precision Virologics, Inc.
 Precision Virologics, Inc. BiotechnologyHealth Technology Precision Virologics, Inc. develops biologically targeted vaccines for emerging infectious diseases. The company was founded by David T. Curiel in 2017 and is headquartered in Saint Louis, MO. | Gründer | - | - |
| The University of Alabama | Corporate Officer/Principal | - | - |
Ausbildung von David Curiel
| Emory University | Undergraduate Degree |
| University of Groningen | Doctorate Degree |
| University of Washington | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Niederlande | 2 |
| Deutschland | 2 |
Operativ
| Director/Board Member | 2 |
| Founder | 2 |
| Corporate Officer/Principal | 2 |
Sektoral
| Consumer Services | 5 |
| Health Technology | 4 |
| Miscellaneous | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Vectorlogics, Inc.
Vectorlogics, Inc. BiotechnologyHealth Technology Vectorlogics, Inc. develops and commercialized vaccines for virus based cancer therapies and viral liver diseases. The company was founded by David T. Curiel in 1998 and is headquartered in Birmingham, AL. | Health Technology |
Provecs Medical GmbH
Provecs Medical GmbH BiotechnologyHealth Technology Provecs Medical GmbH develops therapeutic vaccines. It focuses in providing treatment options for patients with advanced cancer and infectious diseases. The company was founded by Frank Schnieders and Hansjoerg Forster in 2007 and is headquartered in Hamburg, Germany. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Precision Virologics, Inc.
Precision Virologics, Inc. BiotechnologyHealth Technology Precision Virologics, Inc. develops biologically targeted vaccines for emerging infectious diseases. The company was founded by David T. Curiel in 2017 and is headquartered in Saint Louis, MO. | Health Technology |
- Börse
- Insiders
- David Curiel
- Erfahrung
